Enliven Therapeutics, Inc. (ELVN) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2, 3
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-01-10
1:13 pm
Sale
2021-12-2713DIMARA INC
IMRA
New Enterprise Associates 14, L.P.3,695,192
14.100%
-318,803decrease
(-7.94%)
Filing
History
2021-09-10
09:33 am
Sale
2021-09-0913GIMARA INC
IMRA
FMR LLC2,310,359
8.802%
-300,757decrease
(-11.52%)
Filing
History
2021-07-20
4:21 pm
Purchase
2021-07-0613DIMARA INC
IMRA
Arix Bioscience plc2,344,072
9.000%
1,275,817increase
(+119.43%)
Filing
History
Goto Prev, 0, 1, 2, 3